ClinicalTrials.gg
Not yet recruitingNCT07945249Updated Nov 18, 2026

Imagery- and Breath-Based Sound Intervention in Health Sciences Students

An interventional study of Imagery- and Breath-Based Sound Intervention and No Interventions in Rumination, Stress and Sleep Disturbance, sponsored by Ataturk University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Ataturk University · Not applicable, Interventional, and Supportive care

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate the effect of an imagery- and breath-based sound intervention on rumination, stress, and sleep quality among health sciences students. Participants will be randomly assigned to either an intervention group receiving a daily guided imagery and breath-based sound program or a control group receiving no intervention. Outcomes will be assessed using validated self-report questionnaires before and after the intervention.

Read the detailed description

Health sciences students frequently experience high levels of academic stress, which may contribute to increased rumination and poor sleep quality. Non-pharmacological interventions that are easy to implement may help improve psychological well-being in this population.

This single-center randomized controlled trial will be conducted among students at Atatürk University Health Services Vocational School. Eligible participants will be randomly allocated to either an intervention group or a control group. The intervention group will receive a daily imagery- and breath-based sound program delivered through a video, while the control group will continue their usual daily activities without any intervention. Rumination, stress, and sleep quality will be measured using the Ruminative Thought Style Questionnaire, the Depression Anxiety Stress Scale-21 (DASS-21), and the PROMIS Sleep Disturbance Short Form. The findings will provide evidence regarding the effectiveness of this non-pharmacological intervention for improving students' psychological well-being and sleep quality.

02

Conditions studied

  • Rumination
  • Stress
  • Sleep Disturbance

Keywords

  • Guided Imagery
  • Breath-Based Sound Intervention
  • Rumination
  • Stress
  • Health Sciences Students
  • Non-pharmacological Intervention
  • Randomized Controlled Trial
  • Sleep Disturbance
03

In context

Lead sponsor

Ataturk University is the lead sponsor of 462 studies on the registry; 124 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergraduate student enrolled at Atatürk University Health Services Vocational School.
  • Aged 18 years or older.
  • Willing to participate and provide written .
  • No self-reported psychological disorder.

Exclusion criteria

Exclusion Criteria:

  • Self-reported psychological disorder.
  • Incomplete completion of the study questionnaires.
  • Withdrawal from the study before completion.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Imagery- and Breath-Based Sound Intervention

    Participants will receive a daily guided imagery and breath-based sound intervention delivered through a pre-recorded video during the study period.

    Behavioral: Imagery- and Breath-Based Sound Intervention

  • Active comparator
    No Intervention

    Participants will continue their usual daily activities and will not receive any intervention during the study period.

    Other: No Interventions

Interventions

  • BehavioralImagery- and Breath-Based Sound Intervention

    Participants will receive a daily guided imagery and breath-based sound intervention delivered through a pre-recorded video during the study period.

  • OtherNo Interventions

    Participants will continue their usual daily activities and will not receive any intervention during the study period.

06

What researchers measure

Primary outcomes

  1. Ruminative Thinking Style Scale (Appendix-2)

    Developed by Brinker and Dozois, this scale attempts to understand an individual's general thought patterns, disregarding their current emotions and mood. This scale can also be used in other pathological conditions. The Ruminative Thinking Style Scale uses a 7-point Likert scale from 1 to 7, where 1 means "not descriptive at all" and 7 means "describes me very well."

    Time frame: Baseline and immediately after the intervention

Secondary outcomes

  1. Depression, Anxiety, Stress (DASS21) Scale (Appendix-3)

    The Depression, Anxiety, Stress Scale (DASS), developed by Lovibond and Lovibond (1995), consists of 42 items. Brown et al. (1997) stated that shorter forms of this scale also have the same validity to perform the same measurement. The 21-item DASS scale used in this study was taken from the studies of Henry and Crawford (2005) and Mahmoud et al. (2010). This scale (DASS-21) contains 7 questions each to measure the dimensions of depression, stress, and anxiety.

    Time frame: Baseline and immediately after the intervention

Other outcomes

  1. Level 2 Sleep Disorder Adult Short Form (PROMIS) (Appendix 4)

    Sleep disorder will be assessed using the Patient Reported Outcome Measurement Information System (PROMIS®) Short Form - Sleep Disorder. All seven items will be rated on a 5-point scale ranging from "Very poor" to "Very good" for item 1 and from "None" to "Very good" for all other items. Item 2 of the scale is reverse coded.

    Time frame: Baseline and immediately after the intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Feb 2027, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2026
First posted
Nov 18, 2026
StartEst.
Dec 12, 2026
Primary completionEst.
Feb 10, 2027
CompletionEst.
Feb 15, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945249
Lead sponsor
Ataturk University
Responsible party
Mine CENGİZ (Lecturer Physician, Ataturk University) — Principal investigator
First posted
Nov 18, 2026
Start date
Dec 12, 2026 (estimated)
Primary completion
Feb 10, 2027 (estimated)
Completion
Feb 15, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Mine Cengiz, lecturer doctor
Contact
mine.cengiz@atauni.edu.tr
+905308864974
Sibel Öztürk, Assoc. Prof.
Contact
sibel.ozturk@atauni.edu.tr
05357951648

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion